Study Group: Current or Former Chief Financial Officers in the Pharmaceuticals & Biotechnology Manufacturing and Research Industry
Council Members in this Study Group: 109
This study group may include chief financial officers, chartered public accountants, controllers, and consultants knowledgeable on topics such as finance, taxation, auditing, forensic accounting and fraud, financial accounting and reporting, bankruptcy, pension benefits, cash flow, company valuation, working capital, hedge accounting, and mergers and acquisition, among others.
Contact Gerson Lehrman Group to survey or consult with members of this Study Group
Leading institutions connect with members of this Study Group through GLG
Leading Experts in this Study Group
Peter CulpepperChief Financial Officer
Provectus Pharmaceuticals, Inc.
Peter Culpepper is the Chief Financial Officer and Chief Operating Officer at Provectus Pharmaceuticals. Mr. Culpepper has experience in prescription (therapeutic), biotech, healthcare OTC, specialty pharma, and medical device products. Previous to that,...
Members in this Study Group include these company types:
- Pharmaceuticals Manufacturer
- Independent Consulting Firm
- Pharmaceuticals/Biotechnology Research Services
- Biotechnology Manufacturer
- Consulting Firm
- Strategic Management
Members in this Study Group often have these job titles:
- Chief Financial Officer
- Consultant
- Chief Executive Officer
- Owner
- President
- Principal
- VP Finance
- Director
Related Study Groups
Gerson Lehrman Group, Inc. connects communities with knowledge through two distinct, yet complementary offerings: GLG Research and G+.